Novel tetravalent bispecific antibody, PSMA/TRAIL?R2 REGULGENT, induces selective tumor cell apoptosis without hepatotoxicity. Nakayama M, Takagi-Maeda S, Machino Y, Nihira K, et al. Oncol Rep 2025;54:155.

Read + Share

Amedeo Smart

Independent Medical Education

Read + Share

Nakayama M, Takagi-Maeda S, Machino Y, Nihira K, et al. Novel tetravalent bispecific antibody, PSMA/TRAIL?R2 REGULGENT, induces selective tumor cell apoptosis without hepatotoxicity. Oncol Rep 2025;54:155.
PMID: 40970352